APO heads into its June 8 results with options traders expressing the most bullish positioning in months — even as insiders quietly trim.
The clearest signal comes from the options market. The put/call ratio dropped to 0.83 on June 4, more than three standard deviations below its 20-day average of 0.88. That is the most call-heavy reading in at least a year, with the 52-week low on PCR at 0.55 still well below current levels but the direction of travel unmistakeable. Call demand has been building steadily since late April, when the PCR sat near 0.92. Separately, short sellers have pulled back: short interest has fallen 5.4% over the past week to 5.3% of the free float, erasing a build that had run through mid-May. Borrow conditions remain easy, with availability near 275% — nearly three times outstanding short interest — and cost to borrow at just 0.52%, even after a sharp 46% jump over the week that still leaves it low in absolute terms.
The Street mostly agrees with the options market's bullish lean. Analysts carry a consensus mean price target of $150.25 against a current price of $128.41 — roughly 17% upside — and recent moves have been largely in one direction. UBS raised its target to $158 in early May while maintaining Buy. Piper Sandler lifted to $157, also while keeping Overweight. Barclays edged higher too. The outlier was TD Cowen, which trimmed from $155 to $146 in mid-May, and Morgan Stanley cut its target materially in late April, though both held positive ratings. The bull case centres on record Retirement Services inflows of $17.2 billion and a $14 billion capital deployment at wider spreads, positioning the firm to capture spread compression as conditions normalise. Bears flag a meaningful downgrade to near-term SRE growth expectations — from roughly 9.5% to mid-single digits — and competitive pressure in the retail channel that could weigh on margin assumptions.
Insider activity runs quietly counter to the bullish flow. Subsidiary President John Zito sold approximately $6.4 million in shares across three transactions on May 27, near the current price. CFO Martin Kelly sold $942,000 in mid-May. Net insider sales over the past 90 days total just over $7.3 million — not large relative to Apollo's scale, but entirely one-directional. Co-founder Marc Rowan trimmed 140,000 shares as of early May, though he retains a 4.7% stake. Capital Research and Management, the largest external institutional holder, added nearly 9.9 million shares as of April 30, a meaningful accumulation that provides a counterweight to the insider selling signal.
The ORTEX short score has eased from a recent high near 61.4 to 58.9, consistent with the short interest unwind. Factor scores add nuance: forward EPS growth ranks in the 88th percentile of the universe on a 12-month basis, but the 90-day EPS momentum rank sits at just 35, suggesting near-term estimate revisions have lost momentum even if the longer view remains constructive. The June 8 print is therefore less a test of whether Apollo can grow and more a question of whether the pace of deployment and Retirement Services inflows can hold up in a quarter where macro crosscurrents have complicated the picture for alternative asset managers.
See the live data behind this article on ORTEX.
Open APO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
